Approval · Notice of Compliance 25552 · 2021
COMPONENT TE-S IMPLANTS WITH TYLAN: Notice of Compliance 25552
Issued March 30, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25552
- Date
- March 30, 2021
- Company
- Elanco Canada LimitedGuelph, Ontario, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Manufacturing changes
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| COMPONENT TE-S IMPLANTS WITH TYLAN | 02245745 | Marketed |
Medicinal ingredients
- ESTRADIOL 24 MG per IMP
- TRENBOLONE ACETATE 120 MG per IMP
- TYLOSIN TARTRATE 29 MG per IMP